Hartford Financial Management’s TG Therapeutics TGTX Stock Holding History

Hartford Financial Management’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.4K	Hold	353	–	–	﹤0.01%	252
2026 Q1	$11.7K	Hold	353	–	–	﹤0.01%	261
2025 Q4	$10.5K	Hold	353	–	–	﹤0.01%	266
2025 Q3	$12.8K	Hold	353	–	–	﹤0.01%	264
2025 Q2	$12.7K	Hold	353	–	–	﹤0.01%	274
2025 Q1	$13.9K	Hold	353	–	–	﹤0.01%	276
2024 Q4	$10.6K	Hold	353	–	–	﹤0.01%	296
2024 Q3	$8.26K	Hold	353	–	–	﹤0.01%	309
2024 Q2	$6.28K	Hold	353	–	–	﹤0.01%	319
2024 Q1	$5.37K	Hold	353	–	–	﹤0.01%	329
2023 Q4	$6.03K	Hold	353	–	–	﹤0.01%	330
2023 Q3	$2.95K	Hold	353	–	–	﹤0.01%	353
2023 Q2	$8.77K	Hold	353	–	–	﹤0.01%	293
2023 Q1	$5.31K	Hold	353	–	–	﹤0.01%	309
2022 Q4	$4.18K	Hold	353	–	–	﹤0.01%	313
2022 Q3	$2K	Hold	353	–	–	﹤0.01%	360
2022 Q2	$2K	Hold	353	–	–	﹤0.01%	366
2022 Q1	$3K	Hold	353	–	–	﹤0.01%	359
2021 Q4	$7K	Hold	353	–	–	﹤0.01%	309
2021 Q3	$12K	Hold	353	–	–	﹤0.01%	281
2021 Q2	$14K	Hold	353	–	–	﹤0.01%	276
2021 Q1	$17K	Buy	353 +158	+81%	+$7.59K	﹤0.01%	263
2020 Q4	$10K	Hold	195	–	–	﹤0.01%	286
2020 Q3	$5K	Hold	195	–	–	﹤0.01%	293
2020 Q2	$4K	Hold	195	–	–	﹤0.01%	308
2020 Q1	$2K	Buy	+195	New	+$2.46K	﹤0.01%	331

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Hartford Financial Management's TGTX Position: Q2 2026 in Review

Hartford Financial Management held its TG Therapeutics (TGTX) position steady in Q2 2026 at 353 shares worth $19.4K. The position accounts for ﹤0.01% of the portfolio, ranked #252.

Hartford Financial Management first reported a position in TGTX in Q1 2020 and has held it in 26 quarters since. 430 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Hartford Financial Management held 353 shares of TG Therapeutics worth $19.4K as of Q2 2026.
Hartford Financial Management left its TG Therapeutics share count unchanged in Q2 2026.
TG Therapeutics made up ﹤0.01% of Hartford Financial Management's portfolio in Q2 2026, its #252 holding.
Hartford Financial Management first reported a position in TG Therapeutics in Q1 2020 and has held it in 26 quarters since.
430 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Hartford Financial Management's 13F filing for Q2 2026, filed 24 Jul 2026.